Skip to main content
Terug
PHVS logo

Pharvaris N.V.

Datakwaliteit: 100%
PHVS
NASDAQ Healthcare Biotechnology
€ 25,70
▼ € 0,30 (-1,15%)
Marktkapitalisatie: 1,67B
Dagbereik
€ 25,17 € 27,13
52-Weeksbereik
€ 11,51 € 29,80
Volume
217.413
50D / 200D Gem.
€ 26,82 / € 23,56
Vorige Slotkoers
€ 26,00

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -12,4 0,4
P/B 6,2 2,9
ROE % -41,2 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Belangrijkste Punten

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -120,67M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-41,18%
ROIC-40,68%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,00
Current Ratio12,60
Interest Coverage0,00

Waardering

P/E Ratio
-12,44
P/B Ratio6,23
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -134,22M
ROE -41,18% ROA -46,06%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -120,67M
ROIC -40,68% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 12,60
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -12,44 P/B Ratio 6,23
P/S Ratio N/A PEG Ratio 1,31
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,67B Enterprise Value 1,39B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -134,22M -100,88M -76,33M -42,73M -29,62M
EPS (Diluted) -2,48 -2,63 -2,27 -1,41 -0,85
Gross Profit 0,0 0,0 0,0 0,0 -8.436,95
Operating Income -145,69M -96,91M -86,71M -54,14M -28,51M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 291,37M 398,69M 167,73M 212,09M 101,10M
Total Liabilities 23,61M 14,65M 18,47M 7,14M 5,31M
Shareholders' Equity 267,76M 384,05M 149,26M 204,95M 95,79M
Total Debt 861.470,0 238.905,0 436.822,0 250.184,0 0,0
Cash & Equivalents 280,73M 391,23M 161,84M 209,35M 98,63M
Current Assets 289,42M 397,85M 166,85M 211,57M 100,95M
Current Liabilities 22,97M 14,60M 18,22M 6,99M 5,31M